NCCN GUIDELINES® INSIGHTS: Prostate Cancer, Version 1.2023: Featured Updates to the NCCN Guidelines

Edward M. Schaeffer; Sandy Srinivas; Nabil Adra; Yi An; Daniel Barocas; Rhonda Bitting; Alan Bryce; Brian Chapin; Heather H. Cheng; Anthony Victor D'Amico; Neil Desai; Tanya Dorff; James A. Eastham; Thomas A. Farrington; Xin Gao; Shilpa Gupta; Thomas Guzzo; Joseph E. Ippolito; Michael R. Kuettel; Joshua M. Lang; Tamara Lotan; Rana R. McKay; Todd Morgan; George Netto; Julio M. Pow-Sang; Robert Reiter; Mack Roach; Tyler Robin; Stan Rosenfeld; Ahmad Shabsigh; Daniel Spratt; Benjamin A. Teply; Jonathan Tward; Richard Valicenti; Jessica Karen Wong; Ryan A. Berardi; Dorothy A. Shead; Deborah A. Freedman-Cass

doi:10.6004/jnccn.2022.0063

NCCN GUIDELINES® INSIGHTS: Prostate Cancer, Version 1.2023: Featured Updates to the NCCN Guidelines

Edward M. Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Daniel Barocas, Rhonda Bitting, Alan Bryce, Brian Chapin, Heather H. Cheng, Anthony Victor D'Amico, Neil Desai, Tanya Dorff, James A. Eastham, Thomas A. Farrington, Xin Gao, Shilpa Gupta, Thomas Guzzo, Joseph E. Ippolito, Michael R. Kuettel, Joshua M. LangTamara Lotan, Rana R. McKay, Todd Morgan, George Netto, Julio M. Pow-Sang, Robert Reiter, Mack Roach, Tyler Robin, Stan Rosenfeld, Ahmad Shabsigh, Daniel Spratt, Benjamin A. Teply, Jonathan Tward, Richard Valicenti, Jessica Karen Wong, Ryan A. Berardi, Dorothy A. Shead, Deborah A. Freedman-Cass

Radiation Oncology

Research output: Contribution to journal › Article › peer-review

151 Scopus citations

Abstract

The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, recurrent, and metastatic disease. The NCCN Prostate Cancer Panel meets annually to reevaluate and update their recommendations based on new clinical data and input from within NCCN Member Institutions and from external entities. These NCCN Guidelines Insights summarizes much of the panel's discussions for the 4.2022 and 1.2023 updates to the guidelines regarding systemic therapy for metastatic prostate cancer.

Original language	English
Pages (from-to)	1288-1298
Number of pages	11
Journal	Journal of the National Comprehensive Cancer Network : JNCCN
Volume	20
Issue number	12
DOIs	https://doi.org/10.6004/jnccn.2022.0063
State	Published - Dec 2022

Keywords

Humans
Male
Prostatic Neoplasms/diagnosis
Risk Assessment

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.6004/jnccn.2022.0063

Cite this

Schaeffer, E. M., Srinivas, S., Adra, N., An, Y., Barocas, D., Bitting, R., Bryce, A., Chapin, B., Cheng, H. H., D'Amico, A. V., Desai, N., Dorff, T., Eastham, J. A., Farrington, T. A., Gao, X., Gupta, S., Guzzo, T., Ippolito, J. E., Kuettel, M. R., ... Freedman-Cass, D. A. (2022). NCCN GUIDELINES® INSIGHTS: Prostate Cancer, Version 1.2023: Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network : JNCCN, 20(12), 1288-1298. https://doi.org/10.6004/jnccn.2022.0063

@article{9bfc06e126674b2abe453e8788cc564c,

title = "NCCN GUIDELINES{\textregistered} INSIGHTS: Prostate Cancer, Version 1.2023: Featured Updates to the NCCN Guidelines",

abstract = "The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, recurrent, and metastatic disease. The NCCN Prostate Cancer Panel meets annually to reevaluate and update their recommendations based on new clinical data and input from within NCCN Member Institutions and from external entities. These NCCN Guidelines Insights summarizes much of the panel's discussions for the 4.2022 and 1.2023 updates to the guidelines regarding systemic therapy for metastatic prostate cancer.",

keywords = "Humans, Male, Prostatic Neoplasms/diagnosis, Risk Assessment",

author = "Schaeffer, {Edward M.} and Sandy Srinivas and Nabil Adra and Yi An and Daniel Barocas and Rhonda Bitting and Alan Bryce and Brian Chapin and Cheng, {Heather H.} and D'Amico, {Anthony Victor} and Neil Desai and Tanya Dorff and Eastham, {James A.} and Farrington, {Thomas A.} and Xin Gao and Shilpa Gupta and Thomas Guzzo and Ippolito, {Joseph E.} and Kuettel, {Michael R.} and Lang, {Joshua M.} and Tamara Lotan and McKay, {Rana R.} and Todd Morgan and George Netto and Pow-Sang, {Julio M.} and Robert Reiter and Mack Roach and Tyler Robin and Stan Rosenfeld and Ahmad Shabsigh and Daniel Spratt and Teply, {Benjamin A.} and Jonathan Tward and Richard Valicenti and Wong, {Jessica Karen} and Berardi, {Ryan A.} and Shead, {Dorothy A.} and Freedman-Cass, {Deborah A.}",

year = "2022",

month = dec,

doi = "10.6004/jnccn.2022.0063",

language = "English",

volume = "20",

pages = "1288--1298",

journal = "Journal of the National Comprehensive Cancer Network : JNCCN",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "12",

}

Schaeffer, EM, Srinivas, S, Adra, N, An, Y, Barocas, D, Bitting, R, Bryce, A, Chapin, B, Cheng, HH, D'Amico, AV, Desai, N, Dorff, T, Eastham, JA, Farrington, TA, Gao, X, Gupta, S, Guzzo, T, Ippolito, JE, Kuettel, MR, Lang, JM, Lotan, T, McKay, RR, Morgan, T, Netto, G, Pow-Sang, JM, Reiter, R, Roach, M, Robin, T, Rosenfeld, S, Shabsigh, A, Spratt, D, Teply, BA, Tward, J, Valicenti, R, Wong, JK, Berardi, RA, Shead, DA & Freedman-Cass, DA 2022, 'NCCN GUIDELINES® INSIGHTS: Prostate Cancer, Version 1.2023: Featured Updates to the NCCN Guidelines', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 20, no. 12, pp. 1288-1298. https://doi.org/10.6004/jnccn.2022.0063

TY - JOUR

T1 - NCCN GUIDELINES® INSIGHTS

T2 - Prostate Cancer, Version 1.2023: Featured Updates to the NCCN Guidelines

AU - Schaeffer, Edward M.

AU - Srinivas, Sandy

AU - Adra, Nabil

AU - An, Yi

AU - Barocas, Daniel

AU - Bitting, Rhonda

AU - Bryce, Alan

AU - Chapin, Brian

AU - Cheng, Heather H.

AU - D'Amico, Anthony Victor

AU - Desai, Neil

AU - Dorff, Tanya

AU - Eastham, James A.

AU - Farrington, Thomas A.

AU - Gao, Xin

AU - Gupta, Shilpa

AU - Guzzo, Thomas

AU - Ippolito, Joseph E.

AU - Kuettel, Michael R.

AU - Lang, Joshua M.

AU - Lotan, Tamara

AU - McKay, Rana R.

AU - Morgan, Todd

AU - Netto, George

AU - Pow-Sang, Julio M.

AU - Reiter, Robert

AU - Roach, Mack

AU - Robin, Tyler

AU - Rosenfeld, Stan

AU - Shabsigh, Ahmad

AU - Spratt, Daniel

AU - Teply, Benjamin A.

AU - Tward, Jonathan

AU - Valicenti, Richard

AU - Wong, Jessica Karen

AU - Berardi, Ryan A.

AU - Shead, Dorothy A.

AU - Freedman-Cass, Deborah A.

PY - 2022/12

Y1 - 2022/12

N2 - The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, recurrent, and metastatic disease. The NCCN Prostate Cancer Panel meets annually to reevaluate and update their recommendations based on new clinical data and input from within NCCN Member Institutions and from external entities. These NCCN Guidelines Insights summarizes much of the panel's discussions for the 4.2022 and 1.2023 updates to the guidelines regarding systemic therapy for metastatic prostate cancer.

AB - The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, recurrent, and metastatic disease. The NCCN Prostate Cancer Panel meets annually to reevaluate and update their recommendations based on new clinical data and input from within NCCN Member Institutions and from external entities. These NCCN Guidelines Insights summarizes much of the panel's discussions for the 4.2022 and 1.2023 updates to the guidelines regarding systemic therapy for metastatic prostate cancer.

KW - Humans

KW - Male

KW - Prostatic Neoplasms/diagnosis

KW - Risk Assessment

UR - http://www.scopus.com/inward/record.url?scp=85143993549&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2022.0063

DO - 10.6004/jnccn.2022.0063

M3 - Article

C2 - 36509074

AN - SCOPUS:85143993549

SN - 1540-1405

VL - 20

SP - 1288

EP - 1298

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

IS - 12

ER -

NCCN GUIDELINES® INSIGHTS: Prostate Cancer, Version 1.2023: Featured Updates to the NCCN Guidelines

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this